Nippon Shinyaku Co Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Nippon Shinyaku Co Ltd with three other
companies in this sector in Japan:
Mochida Pharmaceutical Company Limited
sales of 97.35 billion Japanese Yen [US$875.17 million]
Kaken Pharmaceutical Co Ltd
(101.48 billion Japanese Yen [US$912.30 million]
Towa Pharmaceutical Company Limited
(84.95 billion Japanese Yen [US$763.69 million]
During the year ended March of 2017, sales at
Nippon Shinyaku Co Ltd were ¥98.78 billion (US$888.04 million).
increase of 17.3%
versus 2016, when the company's sales were ¥84.21 billion.
This was the fifth consecutive year of sales increases at Nippon Shinyaku Co Ltd
(and since 2012, sales have increased a total of 47%).